Department of Microbiology and Immunology, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
PLoS One. 2011 Feb 28;6(2):e17246. doi: 10.1371/journal.pone.0017246.
The nature of the interaction between replicating HIV-1 and the cellular RNAi pathway has been controversial, but it is clear that it can be complex and multifaceted. It has been proposed that the interaction is bi-directional, whereby cellular silencing pathways can restrict HIV-1 replication, and in turn, HIV-1 can suppress silencing pathways. Overall suppression of RNAi has been suggested to occur via direct binding and inhibition of Dicer by the HIV-1 Tat protein or through sequestration of TRBP, a Dicer co-factor, by the structured TAR element of HIV-1 transcripts. The role of Tat as an inhibitor of Dicer has been questioned and our results support and extend the conclusion that Tat does not inhibit RNAi that is mediated by either exogenous or endogenous miRNAs. Similarly, we find no suppression of silencing pathways in cells with replicating virus, suggesting that viral products such as the TAR RNA elements also do not reduce the efficacy of cellular RNA silencing. However, knockdown of Dicer does allow increased viral replication and this occurs at a post-transcriptional level. These results support the idea that although individual miRNAs can act to restrict HIV-1 replication, the virus does not counter these effects through a global suppression of RNAi synthesis or processing.
HIV-1 复制与细胞 RNAi 途径之间相互作用的性质一直存在争议,但很明显,这种相互作用可能是复杂和多方面的。有人提出,这种相互作用是双向的,细胞沉默途径可以限制 HIV-1 的复制,而 HIV-1 反过来又可以抑制沉默途径。据推测,HIV-1 Tat 蛋白通过直接结合和抑制 Dicer,或通过 HIV-1 转录本 TAR 元件对 Dicer 辅助因子 TRBP 的隔离,导致 RNAi 的整体抑制。Tat 作为 Dicer 抑制剂的作用一直受到质疑,我们的结果支持并扩展了结论,即 Tat 不会抑制由外源性或内源性 miRNAs 介导的 RNAi。同样,我们在复制病毒的细胞中没有发现沉默途径的抑制,这表明病毒产物,如 TAR RNA 元件,也不会降低细胞 RNA 沉默的效果。然而,Dicer 的敲低确实允许病毒复制增加,这发生在转录后水平。这些结果支持这样一种观点,即尽管个别 miRNAs 可以起到限制 HIV-1 复制的作用,但病毒并没有通过对 RNAi 合成或加工的全局抑制来对抗这些作用。